Headache Journal

Headache Research Library

New Research Explores Migraine and Opioids

Recent studies have shown that of people with migraine who take acute prescription medications, more than a third keep opioids on hand to relieve their attacks.“

Read More

Examining the experiences of patients with new daily persistent headache

Jessica Gautreaux, MD, reviews the first qualitative descriptive study on NDPH

Read More

Healthcare Provider Wellness During COVID-19

Dawn Buse, PhD, FAHS, discusses some of the challenges faced by healthcare providers during the pandemic and ways to prioritize self-care.

Read More

Brad Klein: Member Spotlight

Honoree Brad Klein, MD, MBA, FAHS, talks about the importance of advocacy and business acumen in headache medicine

Read More

Telemedicine in the Age of the COVID-19 Pandemic

An article recently published in Cephalalgia examines whether synchronous video-based telemedicine visits with specialists are feasible, and evaluates clinical effectiveness, patient perceptions, and other benefits of telemedicine visits for follow-up migraine care in a tertiary headache center.

Read More

Headache Clinic Workflows During the COVID-19 Pandemic

Telemedicine and precaution can provide relief safely, according to Nina Riggins, MD, Ph.D, and Rashmi Halker Singh, MD, FAHS, FAAN

Read More

Cluster Headache Patients Experience Interictal Symptoms in Addition to Pain

According to a new study published in Headache®, patients who live with cluster headache—characterized by excruciatingly painful attacks lasting 15-180 minutes — experience ongoing symptoms even between attacks.

Read More

MAST Study Identifies Most Bothersome Symptom (MBS) for Patients with Migraine

Among nausea, phonophobia, and photophobia, one of these symptoms are reported as the most bothersome symptoms (MBS) in individuals with migraine.

Read More

Breaking News: Eptinezumab-jjmr (VYEPTI™) Approved by FDA

Eptinezumab, the first intravenous treatment for migraine prevention, approved by the FDA

Read More

Options for Treating Refractory Pediatric Migraine

A recent paper in Headache® found that combining outpatient DHE infusion with interdisciplinary adjunctive care has promise as an effective treatment option for adolescents with refractory migraine.

Read More

The Future of Neuromodulation: Q&A

Michael L. Oshinsky, PhD, discusses how headache researchers can shape the future of neuromodulation 

Read More

The Genetics of Migraine: Q&A

It is widely accepted that migraine has a genetic component. But the genetics of migraine and how the disease develops is not yet well understood.  

Read More

Headache Specialists vs. Non-Headache Specialists for Pediatric Treatments: A Review

Management practices for children with migraine vary between headache specialists and non-headache specialists. But these differences need to be overcome in order to better serve headache patients. 

Read More

Familial vs. Sporadic Migraine: Study Finds Little Difference

Research shows that migraine is a complex disease. There are suspicions that there is a considerable genetic component involved with migraine. It is unknown, however, if this plays a role in disease severity, leading researchers to compare familial and sporadic migraine.

Read More